FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist (Q56908222)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist |
article |
Statements
FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist (English)
1 September 2007